Deutsche Bank’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-58,086
| Closed | -$717K | – | 3674 |
|
|
2024
Q4 | $717K | Buy |
58,086
+20,249
| +54% | +$232K | ﹤0.01% | 2429 |
|
|
2024
Q3 | $431K | Buy |
37,837
+4,875
| +15% | +$48.9K | ﹤0.01% | 2544 |
|
|
2024
Q2 | $235K | Sell |
32,962
-812
| -2% | -$6.21K | ﹤0.01% | 2714 |
|
|
2024
Q1 | $226K | Sell |
33,774
-64,874
| -66% | -$446K | ﹤0.01% | 2764 |
|
|
2023
Q4 | $641K | Buy |
98,648
+64,798
| +191% | +$418K | ﹤0.01% | 2249 |
|
|
2023
Q3 | $320K | Buy |
33,850
+3,851
| +13% | +$46.3K | ﹤0.01% | 2471 |
|
|
2023
Q2 | $419K | Sell |
29,999
-82,417
| -73% | -$1.4M | ﹤0.01% | 2454 |
|
|
2023
Q1 | $2.11M | Buy |
112,416
+79,184
| +238% | +$1.3M | ﹤0.01% | 1664 |
|
|
2022
Q4 | $458K | Buy |
33,232
+4,277
| +15% | +$65.5K | ﹤0.01% | 2490 |
|
|
2022
Q3 | $553K | Sell |
28,955
-6,495
| -18% | -$118K | ﹤0.01% | 2316 |
|
|
2022
Q2 | $541K | Sell |
35,450
-2,121
| -6% | -$31.4K | ﹤0.01% | 2546 |
|
|
2022
Q1 | $765K | Sell |
37,571
-3,765
| -9% | -$76.7K | ﹤0.01% | 2508 |
|
|
2021
Q4 | $1.21M | Buy |
41,336
+1,685
| +4% | +$48.2K | ﹤0.01% | 2320 |
|
|
2021
Q3 | $855K | Sell |
39,651
-20,803
| -34% | -$502K | ﹤0.01% | 2721 |
|
|
2021
Q2 | $1.55M | Buy |
60,454
+1,144
| +2% | +$24.4K | ﹤0.01% | 2457 |
|
|
2021
Q1 | $1.08M | Buy |
59,310
+7,286
| +14% | +$121K | ﹤0.01% | 2615 |
|
|
2020
Q4 | $600K | Buy |
52,024
+16,175
| +45% | +$148K | ﹤0.01% | 2779 |
|
|
2020
Q3 | $274K | Buy |
35,849
+7,830
| +28% | +$59.3K | ﹤0.01% | 3027 |
|
|
2020
Q2 | $183K | Buy |
28,019
+1,295
| +5% | +$7.23K | ﹤0.01% | 3179 |
|
|
2020
Q1 | $137K | Sell |
26,724
-37,158
| -58% | -$225K | ﹤0.01% | 3121 |
|
|
2019
Q4 | $489K | Buy |
63,882
+47,466
| +289% | +$277K | ﹤0.01% | 2729 |
|
|
2019
Q3 | $86K | Sell |
16,416
-27,313
| -62% | -$170K | ﹤0.01% | 3634 |
|
|
2019
Q2 | $243K | Sell |
43,729
-47,552
| -52% | -$196K | ﹤0.01% | 3708 |
|
|
2019
Q1 | $387K | Sell |
91,281
-83,564
| -48% | -$341K | ﹤0.01% | 3605 |
|
|
2018
Q4 | $716K | Buy |
174,845
+59,116
| +51% | +$308K | ﹤0.01% | 3103 |
|
|
2018
Q3 | $795K | Buy |
115,729
+18,503
| +19% | +$110K | ﹤0.01% | 3496 |
|
|
2018
Q2 | $381K | Buy |
97,226
+82,070
| +542% | +$285K | ﹤0.01% | 3986 |
|
|
2018
Q1 | $44K | Buy |
15,156
+15,143
| +116,485% | +$46.8K | ﹤0.01% | 4795 |
|
|
2017
Q4 | $0 | Sell |
13
-8,384
| -100% | -$35.9K | ﹤0.01% | 5179 |
|
|
2017
Q3 | $26K | Buy |
+8,397
| New | +$31.5K | ﹤0.01% | 4515 |
|
|
2017
Q1 | – | Sell |
-8,494
| Closed | -$18K | – | 5133 |
|
|
2016
Q4 | $18K | Sell |
8,494
-64,774
| -88% | -$151K | ﹤0.01% | 4620 |
|
|
2016
Q3 | $220K | Buy |
+73,268
| New | +$197K | ﹤0.01% | 3603 |
|
|
2016
Q2 | – | Sell |
-5,072
| Closed | -$14.1K | – | 5373 |
|
|
2016
Q1 | $14K | Sell |
5,072
-7,074
| -58% | -$37.9K | ﹤0.01% | 4742 |
|
|
2015
Q4 | $97K | Buy |
12,146
+4,283
| +54% | +$34.6K | ﹤0.01% | 4072 |
|
|
2015
Q3 | $56K | Sell |
7,863
-129,670
| -94% | -$1.08M | ﹤0.01% | 4392 |
|
|
2015
Q2 | $1.26M | Buy |
137,533
+137,496
| +371,611% | +$1.32M | ﹤0.01% | 2811 |
|
|
2015
Q1 | $0 | Buy |
37
+22
| +147% | +$212 | ﹤0.01% | 6085 |
|
|
2014
Q4 | $0 | Sell |
15
-225
| -94% | -$2.27K | ﹤0.01% | 6349 |
|
|
2014
Q3 | $2K | Sell |
240
-2,998
| -93% | -$33.6K | ﹤0.01% | 5682 |
|
|
2014
Q2 | $42K | Sell |
3,238
-7,154
| -69% | -$90.2K | ﹤0.01% | 5007 |
|
|
2014
Q1 | $137K | Buy |
10,392
+5,908
| +132% | +$77.8K | ﹤0.01% | 4093 |
|
|
2013
Q4 | $43K | Sell |
4,484
-21,300
| -83% | -$200K | ﹤0.01% | 4416 |
|
|
2013
Q3 | $252K | Buy |
25,784
+14,100
| +121% | +$140K | ﹤0.01% | 3975 |
|
|
2013
Q2 | $104K | Buy |
+11,684
| New | +$122K | ﹤0.01% | 4203 |
|
Other funds holding CDMO
Deutsche Bank's CDMO Position: Q1 2025 in Review
Deutsche Bank sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2025, closing a stake of 58,086 shares — an estimated $717K sold.
Deutsche Bank first reported a position in CDMO in Q2 2013 and held it in 44 quarters. The position peaked at $2.11M in Q1 2023. 2 funds tracked by Wall St. Rank hold CDMO as of Q1 2025.
- Deutsche Bank reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
- Deutsche Bank sold 58,086 Avid Bioservices, Inc. Common Stock shares in Q1 2025, an estimated $717K.
- Deutsche Bank first reported a position in Avid Bioservices, Inc. Common Stock in Q2 2013 and held it in 44 quarters.
- Deutsche Bank's Avid Bioservices, Inc. Common Stock position peaked at $2.11M in Q1 2023.
- 2 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2025.
Based on Deutsche Bank's 13F filing for Q1 2025, filed 9 May 2025.